STRENCARA

Table of contents:
Trademark domain
nameis free?
strencara.com

The "STRENCARA" trademark, serial number 78685447 , was filed on 4th of August 2005 with a mark drawing code of 4000 and its transaction date is 78685447. The attorney assigned is Nadine P. Flynn, attorney docket number . Since 26th of January 2010, the document can be found in the L50 law office in the publication and issue section. The employee responsible is YONTEF, DAVID ERIC and the date it was published for opposition on 06/27/2006. The status of this trademark was checked last on 01/25/2010.

Other trademarks by this attorney include , PLERATRA , ACUBILITY , ERZELBA . The corresponded responsible for this trademark is Nadine P. Flynn, located at BRISTOL-MYERS SQUIBB COMPANY, Trademark Department, 345 Park Avenue.

The state or country where the trademark was organized is NY by Bristol-myers Squibb Company. The legal entity type behing it is a Corporation, located at 345 Park Avenue, New York, NY zip 10154.Other trademarks by this applicant: REAL POSSIBILITIES, MYCAMBA, MICAMBA.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date08/10/2005
Primary Code005
Goods codes
GS0051Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibody; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents
PROSECUTION HISTORY
DateDescriptionTypeCode
05/17/2007 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
01/25/2010 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
01/25/2010 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
05/11/2009 EXTENSION 5 GRANTED S EX5G - EXTENSION 5 GRANTED
05/11/2009 EXTENSION 5 FILED S EXT5 - EXTENSION 5 FILED
05/11/2009 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
12/01/2008 EXTENSION 4 GRANTED S EX4G - EXTENSION 4 GRANTED
12/01/2008 EXTENSION 4 FILED S EXT4 - EXTENSION 4 FILED
12/01/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
05/02/2008 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
05/02/2008 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
05/02/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
11/09/2007 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
11/09/2007 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
11/09/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
05/17/2007 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
05/17/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
12/26/2006 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
11/10/2006 EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED T - TTAB Proceeding ETOP - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/19/2006 EXTENSION OF TIME TO OPPOSE RECEIVED T - TTAB Proceeding ETOF - EXTENSION OF TIME TO OPPOSE RECEIVED
06/27/2006 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
06/07/2006 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
05/09/2006 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
05/05/2006 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
05/01/2006 EXAMINERS AMENDMENT MAILED O - Outgoing Correspondence CNEA - EXAMINERS AMENDMENT MAILED
04/29/2006 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
04/29/2006 EXAMINER'S AMENDMENT ENTERED I - Incoming Correspondence XAEC - EXAMINER'S AMENDMENT ENTERED
04/29/2006 EXAMINERS AMENDMENT -WRITTEN R - Renewal CNEA - EXAMINERS AMENDMENT -WRITTEN
04/28/2006 TEAS/EMAIL CORRESPONDENCE ENTERED I - Incoming Correspondence TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2006 CORRESPONDENCE RECEIVED IN LAW OFFICE I - Incoming Correspondence CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2006 TEAS RESPONSE TO OFFICE ACTION RECEIVED I - Incoming Correspondence TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2005 PRIORITY ACTION MAILED F - First Action CPRA - PRIORITY ACTION MAILED
11/18/2005 PRIORITY ACTION WRITTEN R - Renewal CPRA - PRIORITY ACTION WRITTEN
11/17/2005 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
08/10/2005 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.